Duality Advisers’s Nu Skin NUS Stock Holding History

Duality Advisers’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35,752	Closed	-$758K	–	695
2023 Q3	$758K	Buy	+35,752	New	+$929K	0.09%	350
2022 Q3	–	Sell	-61,937	Closed	-$2.68M	–	681
2022 Q2	$2.68M	Buy	+61,937	New	+$2.84M	0.26%	137

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Duality Advisers's NUS Position: Q4 2023 in Review

Duality Advisers sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 35,752 shares — an estimated $758K sold.

Duality Advisers first reported a position in NUS in Q2 2022 and held it in 2 quarters. The position peaked at $2.68M in Q2 2022. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.

Duality Advisers reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
Duality Advisers sold 35,752 Nu Skin shares in Q4 2023, an estimated $758K.
Duality Advisers first reported a position in Nu Skin in Q2 2022 and held it in 2 quarters.
Duality Advisers's Nu Skin position peaked at $2.68M in Q2 2022.
212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.